Delivery Order SPE2DB22D1017-SPE2DB24FE7WC
- Not listed
- This federal contract award, SPE2DX15D1053|SPE2DX24F6JUQ, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation. The $7,866.80 firm fixed price delivery order is for the supply of Lamictal 200 mg tablets. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00, with a performance period through December 31, 2025. This IDC serves as the...
- This federal contract award is for the delivery of 4,563,618,757 units of the pharmaceutical drug Lamictal 100 mg tablets. The award was made to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., both of which are registered in the System for Award Management (SAM). The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD), and has a ceiling value of $13,719.94. The contract type is a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,038.01, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of Lamictal XR 200 mg tablets. The contract is a delivery order that falls under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lamotrigine ODT 50 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,125.81 and a period of performance through January 28, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,403.92, is for the delivery of LAMICTAL ODT 200 MG TABLET 30S, a pharmaceutical product. The contract has a completion date of February 5, 2024 and is a Firm Fixed Price Delivery Order. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is a subsidiary of the...
- This federal contract award is from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award, valued at $8,611.21, is for the delivery of Lamictal XR 200 mg tablets. This is a delivery order contract with a firm fixed price, and the ultimate completion date is May 4, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of LAMICTAL XR 300 MG TABLET 30S. The $3,997.28 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, running through November 2026. This IDC serves as the primary vehicle for AmerisourceBergen to supply...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of LAMICTAL XR 50 MG TABLET 30S. The $3,129.43 firm fixed-price delivery order has an ultimate completion date of August 20, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,128.00 firm fixed-price delivery order contract is for the provision of LAMICTAL XR 250 MG TABLET 30S, a pharmaceutical product. The contract has a June 26, 2024 completion date and does not include any set-aside designation. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award, with ID SPE2DX15D1022|SPE2DX25FVCBX, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $3,078.70 firm fixed-price delivery order is for the supply of 60-count Lamictal 200 mg tablets. The contract has an ultimate completion date of February 10, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FE7WCDelivery Order
This federal contract award is for the delivery of pharmaceutical products to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $5,492.99, is a Firm Fixed Price Delivery Order that runs through November 2, 2023. The contract covers the supply of Lamictal 150 mg tablets to support military treatment facilities and other federal healthcare programs. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to the DLA, supporting the healthcare needs of military personnel, veterans, and other federal beneficiaries. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 11/1/23 |